A
$ Value
$137K
Shares
1,800
Price
$76
Filed
Nov 21
Insider
Name
AGUIRRE FERNANDO
Title
—
CIK
0001224983
Roles
Director
Transaction Details
Transaction Date
2025-11-20
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
40,950
Footnotes
Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
Filing Info
AGUIRRE FERNANDO's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | SYF | A | $60K |
| 2025-12-31 | SYF | A | $55K |
| 2025-11-20 | CVS | A | $137K |
| 2025-11-17 | SYF | A | $1K |
| 2025-09-30 | SYF | A | $55K |
| 2025-08-15 | SYF | A | $1K |
| 2025-06-30 | SYF | A | $55K |
| 2025-05-15 | CVS | A | $137K |
| 2025-05-15 | SYF | A | $1K |
Other Insiders at CVS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Nelson Steven H
EVP and President, Aetna
|
$1K | — | 2026-04-01 |
|
Joyner J. David
President, CEO and Chair
|
— | — | 2026-04-01 |
|
Khichi Samrat S.
EVP, CPO and General Counsel
|
— | — | 2026-04-01 |
|
CAPOZZI HEIDI B
EVP and Chief People Officer
|
— | — | 2026-04-01 |
|
Compton-Phillips Amy
EVP, Chief Medical Officer
|
— | — | 2026-03-31 |
|
Clark James David
SVP, Cont & Chief Acct Officer
|
— | — | 2026-04-01 |
|
Newman Brian
EVP, Chief Financial Officer
|
— | — | 2026-03-31 |
|
Mandadi Tilak
EVP, Chief Exp & Tech Officer
|
— | — | 2026-04-01 |
|
Shah Prem S
EVP and Group President
|
— | — | 2026-04-01 |